These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9400920)

  • 1. Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus.
    Coppola L; Verrazzo G; La Marca C; Ziccardi P; Grassia A; Tirelli A; Giugliano D
    Diabet Med; 1997 Nov; 14(11):959-63. PubMed ID: 9400920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients.
    Marfella R; Acampora R; Verrazzo G; Ziccardi P; De Rosa N; Giunta R; Giugliano D
    Diabetes Care; 1996 Sep; 19(9):934-9. PubMed ID: 8875085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.
    Westerveld HT; de Graaf JC; van Breugel HH; Akkerman JW; Sixma JJ; Erkelens DW; Banga JD
    Diabetes Care; 1993 May; 16(5):683-8. PubMed ID: 8495604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants.
    Giugliano D; Marfella R; Verrazzo G; Acampora R; Donzella C; Quatraro A; Coppola L; D'Onofrio F
    Ann Intern Med; 1995 Sep; 123(5):338-43. PubMed ID: 7625621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
    Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
    Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vitamin E administration on platelet function in diabetes mellitus.
    Kunisaki M; Umeda F; Inoguchi T; Watanabe J; Nawata H
    Diabetes Res; 1990 May; 14(1):37-42. PubMed ID: 2134664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood rheology abnormalities in diabetes mellitus].
    Le Devehat C
    J Mal Vasc; 1989; 14(1):64-7. PubMed ID: 2646390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients.
    Trovati M; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Piretto V; Cavalot F; Anfossi G
    Diabetes; 1995 Nov; 44(11):1318-22. PubMed ID: 7589830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No influence of C-peptide, insulin, and glucagon on blood viscosity in vitro in healthy humans and patients with diabetes mellitus.
    Schnyder L; Walter R; Rohrer A; Contesse J; Reinhart WH
    Clin Hemorheol Microcirc; 2001; 24(2):65-74. PubMed ID: 11381181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
    Koltai K; Feher G; Kesmarky G; Keszthelyi Z; Czopf L; Toth K
    Clin Hemorheol Microcirc; 2006; 35(4):517-25. PubMed ID: 17148851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood rheology in patients with diabetes mellitus.
    Le Dévéhat C; Vimeux M; Khodabandehlou T
    Clin Hemorheol Microcirc; 2004; 30(3-4):297-300. PubMed ID: 15258357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus.
    Konya H; Hasegawa Y; Hamaguchi T; Satani K; Umehara A; Katsuno T; Ishikawa T; Miuchi M; Kohri K; Suehiro A; Kakishita E; Miyagawa J; Namba M
    Metabolism; 2010 Sep; 59(9):1294-9. PubMed ID: 20070990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
    Giugliano D; Marfella R; Acampora R; Giunta R; Coppola L; D'Onofrio F
    Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of "Yiqi yangyin huoxue" prescription on hemorrheology of diabetics with symptoms of "qi, yin" deficiency and stasis of blood].
    Liang XC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Apr; 11(2):87-91. PubMed ID: 2528425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood viscosity and erythrocyte filterability: their evaluation in diabetes mellitus.
    Caimi G
    Horm Metab Res; 1983 Oct; 15(10):467-70. PubMed ID: 6642407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood filterability and hemoglobin-oxygen affinity in diabetic patients with and without retinopathy.
    Martins-Silva J; Levy-Cruz F; Freitas JP; Sousa-Ramalho P
    Acta Diabetol Lat; 1984; 21(2):133-9. PubMed ID: 6475452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of ADP-induced platelet aggregation in diabetes mellitus.
    Jones DB; Davis TM; Bown E; Carter RD; Mann JI; Prescott RJ
    Diabetologia; 1986 May; 29(5):291-4. PubMed ID: 3721088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell deformability, platelet aggregation, and insulin action.
    Vague P; Juhan I
    Diabetes; 1983 May; 32 Suppl 2():88-91. PubMed ID: 6400673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.